Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors Didier Lardinois, MD, Renate Rechsteiner, MD, R.Hubert Läng, MD, Matthias Gugger, MD, Daniel Betticher, MD, Christian von Briel, MD, Thorsten Krueger, MD, Hans-Beat Ris, MD The Annals of Thoracic Surgery Volume 69, Issue 5, Pages 1550-1555 (May 2000) DOI: 10.1016/S0003-4975(00)01140-1
Fig 1 Histologic features of thymic tumors according to the Marino and Müller-Hermelink classification. (A) medullary tumor, (B) mixed tumors, (C) organoid tumor, (D) cortical tumor, (E) well-differentiated thymic carcinoma, and (F) endocrine carcinoma (hematoxylin and eosin, original magnification ×400). The Annals of Thoracic Surgery 2000 69, 1550-1555DOI: (10.1016/S0003-4975(00)01140-1)
Fig 2 Kaplan-Meier–generated overall survival curves of patients after complete resection of thymic tumors according to the (A) Masaoka staging and (B) Marino and Müller-Hermelink classification. The Annals of Thoracic Surgery 2000 69, 1550-1555DOI: (10.1016/S0003-4975(00)01140-1)
Fig 3 Kaplan-Meier–generated disease-free survival curves of patients after complete resection of thymic tumors according to the (A) Masaoka staging and (B) Marino and Müller-Hermelink classification. The Annals of Thoracic Surgery 2000 69, 1550-1555DOI: (10.1016/S0003-4975(00)01140-1)